This inventor holds 1 USPTO granted patent. Top assignee: Pierre Fabre Medicament. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Gilbert Alphonse Morales: Innovator in Opioid Dependence Treatment
Introduction
Gilbert Alphonse Morales is a notable inventor and legal representative based in Garrigue, France. He has made significant contributions to the field of pharmaceutical innovations, particularly in the treatment of opioid dependence. His work is characterized by a commitment to developing effective solutions for individuals struggling with addiction.
Latest Patents
Morales holds a patent for "Pyridin-2-yl-methylamine derivatives for treating opiate dependence." This invention focuses on the use of compounds of general formula (I) to address issues related to opioid drug dependence, hyperalgesia induced by opiate drug withdrawal, and psychological craving resulting from withdrawal. His innovative approach aims to provide relief and support for those affected by opioid addiction.
Career Highlights
Throughout his career, Morales has been associated with Pierre Fabre Medicament, a prominent company in the pharmaceutical industry. His role as a legal representative has allowed him to navigate the complexities of patent law while contributing to groundbreaking research and development in drug therapies.
Collaborations
Morales has collaborated with esteemed colleagues such as Francis Colpaert and Liesbeth Bruins Slot. These partnerships have fostered a collaborative environment that enhances the development of innovative treatments in the pharmaceutical sector.
Conclusion
Gilbert Alphonse Morales stands out as a dedicated inventor in the realm of opioid dependence treatment. His patent and collaborative efforts reflect a commitment to improving the lives of individuals facing addiction challenges. His contributions to the field are invaluable and highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
